161 related articles for article (PubMed ID: 3059251)
1. [Prevention of extravasation necroses as a complication following intravenous cytostatic drug therapy. Results of an open pilot study].
Kolarić K; Zupanc D; Stahl KW; Hinz J; Kempf SR; Ivankovic S
Onkologie; 1988 Oct; 11(5):238-40. PubMed ID: 3059251
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experiences with tetrachlorodecaoxide in the local treatment of difficult-to-heal wounds].
Weise K; Evers KH
Aktuelle Traumatol; 1988 Oct; 18(5):219-25. PubMed ID: 2907247
[TBL] [Abstract][Full Text] [Related]
3. Rationale for and results from a randomised, double-blind trial of tetrachlorodecaoxygen anion complex in wound healing.
Hinz J; Hautzinger H; Stahl KW
Lancet; 1986 Apr; 1(8485):825-8. PubMed ID: 2870315
[TBL] [Abstract][Full Text] [Related]
4. Antitumor agents: extravasation, management, and surgical treatment.
Scuderi N; Onesti MG
Ann Plast Surg; 1994 Jan; 32(1):39-44. PubMed ID: 8141535
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory properties of a novel wound healing and immunomodulating agent, tetrachlorodecaoxygen complex (TCDO).
Tissot M; Roch-Arveiller M; Mathieu J; Giroud JP; Stahl KW
Agents Actions; 1990 Nov; 31(3-4):368-74. PubMed ID: 1964762
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Negative-Pressure Wound Therapy with Tetrachlorodecaoxygen-Anion Complex Instillation Compared with Standard Negative-Pressure Wound Therapy for Accelerated Wound Healing: A Prospective, Randomized, Controlled Trial.
Burusapat C; Sringkarawat S
Plast Reconstr Surg; 2021 Aug; 148(2):339-352. PubMed ID: 34153022
[TBL] [Abstract][Full Text] [Related]
7. [The significance of extravasation in oncological care].
Zatkóné Puskás G
Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
[TBL] [Abstract][Full Text] [Related]
8. [Clinical manifestation of extravasation caused by infusion and its therapeutic management].
Altmann S; Damert HG; Schneider W
Zentralbl Chir; 2014 Feb; 139(1):83-8. PubMed ID: 21598203
[TBL] [Abstract][Full Text] [Related]
9. [Increase of oxygen partial pressure and acceleration of wound healing by tetrachlorodecaoxide].
Weiler-Mithoff EM; Friederich HC; Horn W; Issing K
Z Hautkr; 1989 Mar; 64(3):208-11. PubMed ID: 2718552
[TBL] [Abstract][Full Text] [Related]
10. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
[TBL] [Abstract][Full Text] [Related]
11. [Extravasation of cytostatic agents: a serious complication of oncological treatment].
Alfaro-Rubio A; Sanmartín O; Requena C; Llombart B; Botella-Estrada R; Nagore E; Serra-Guillén C; Hueso L; Guillén C
Actas Dermosifiliogr; 2006 Apr; 97(3):169-76. PubMed ID: 16796963
[TBL] [Abstract][Full Text] [Related]
12. Surgical management after doxorubicin and epirubicin extravasation.
Heitmann C; Durmus C; Ingianni G
J Hand Surg Br; 1998 Oct; 23(5):666-8. PubMed ID: 9821616
[TBL] [Abstract][Full Text] [Related]
13. [Healing of arterial and venous ulcers with TCDO. Insight into the mechanisms of tissue repair].
Stahl KW; Chastang C
Fortschr Med; 1988 Jan; 106(1):44-6. PubMed ID: 3350464
[No Abstract] [Full Text] [Related]
14. [Effectiveness of tetrachlorodecaoxide (TCDO) in the treatment of complicated disorders of wound healing. A controlled study: TCDO versus PVP-iodine complex].
Zenker W; Thiede A; Dommes M; Ullmann U
Chirurg; 1986 May; 57(5):334-9. PubMed ID: 3525029
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of chemically-stabilized chlorite-matrix (TCDO) in the management of late postradiation cystitis.
Srisupundit S; Kraiphibul P; Sangruchi S; Linasmita V; Chingskol K; Veerasarn V
J Med Assoc Thai; 1999 Aug; 82(8):798-802. PubMed ID: 10511788
[TBL] [Abstract][Full Text] [Related]
16. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review.
Rudolph R; Larson DL
J Clin Oncol; 1987 Jul; 5(7):1116-26. PubMed ID: 3298560
[TBL] [Abstract][Full Text] [Related]
17. [Soft-tissue defects on the dorsum of the hand by extravasation of the cytostatic agents: surgical options of treatment].
Damert HG; Lenz-Scharf O; Altmann S; Schneider W
Handchir Mikrochir Plast Chir; 2007 Dec; 39(6):409-13. PubMed ID: 18058671
[TBL] [Abstract][Full Text] [Related]
18. Regenerative effects of tetrachlorodecaoxide in BD IX rats after total-body gamma irradiation.
Ivankovic S; Kempf SR
Radiat Res; 1988 Jul; 115(1):115-23. PubMed ID: 3293099
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte macrophage-colony stimulating factor for treatment of chemotherapy extravasation.
Shamseddine AI; Khalil AM; Kibbi AG; Abu Nasr TA; Seoud MA; El Saghir NS
Eur J Gynaecol Oncol; 1998; 19(5):479-81. PubMed ID: 9863917
[No Abstract] [Full Text] [Related]
20. Tetrachlorodecaoxygen, a wound healing agent, produces vascular relaxation through hemoglobulin-dependent inactivation of serotonin and norepinephrine.
Wolin MS; Kleber E; Mohazzab KM; Elstner EF
J Cardiovasc Pharmacol; 1994 Apr; 23(4):664-8. PubMed ID: 7516020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
